Journal Home
Search for

Volume 195, Issue 1, Pages 27-30 (November 2009)


View previous. 7 of 19 View next.

Telomere aggregate formation in placenta specimens of pregnancies complicated with pre-eclampsia

Rivka Sukenik-Halevyab, Moshe Fejginabc, Devora Kidronbd, Lilach Goldberg-Bittmance, Reuven Sharonybc, Tal Biron-Shentalab, Yona Kitay-Cohenbf, Aliza AmielceCorresponding Author Informationemail address

Received 24 February 2009; received in revised form 18 March 2009; accepted 19 March 2009.

Abstract 

Telomeres are specific repetitive DNA sequences that cap and stabilize the ends of chromosomes. Functional telomeres are essential for the normal segregation and maintenance of chromosomes during mitotic and meiotic division. Pre-eclampsia, a pregnancy-specific syndrome of increased blood pressure accompanied by proteinuria, is often associated with growth deficiency in the fetus. Oxidative stress is a major component in the pathophysiology of pre-eclampsia. In contrast to the nonoverlapping nature of telomeres in normal nuclei, telomeres of tumor nuclei tend to form aggregates (TAs) in various numbers and sizes. The formation of TAs represents a stress-related process and is independent of telomere length and telomerase activity. The aim of this study was to evaluate TA formation in paraffin-embedded placentas from pregnancies complicated with pre-eclampsia (study group), compared with placentas from normal pregnancies (control group). There were significantly more TAs in the study group (mean, 8.00 TAs per case) than in the control group (mean, 2.36 TAs per case) (P < 0.01). Pre-eclampsia-related stress may accelerate apoptosis and cell death and lead to placental dysfunction. TAs formation, which has been linked to stress and tumorgenesis is increased in placentas of pre-eclamptic patients.

a Department of OB-GYN, Meir Hospital, Kfar-Saba, Israel

b Sackler School of Medicine, Tel-Aviv University, Ramat-Aviv, Israel

c Genetic Institute, Meir Hospital, Kfar-Saba 44281, Israel

d Department of Pathology, Meir Hospital, Kfar-Saba, Israel

e Faculty of Life Sciences, Bar Ilan University, Ramat-Gan, Israel

f Liver unit, Meir Hospital, Kfar-Saba, Israel

Corresponding Author InformationCorresponding author. Tel.: +972-9-747-2220; fax: +972-9-747-1296.

PII: S0165-4608(09)00184-8

doi:10.1016/j.cancergencyto.2009.03.015


View previous. 7 of 19 View next.